89 filings
8-K
PLXPQ
PLx Pharma Winddown Corp.
20 Sep 23
Bankruptcy or Receivership
4:39pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
22 Aug 23
Other Events
5:24pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
21 Jul 23
Other Events
5:29pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
12 Jul 23
Other Events
12:00am
8-K
PLXPQ
PLx Pharma Winddown Corp.
7 Jul 23
Departure of Directors or Certain Officers
4:16pm
8-K
wd4 43xskm
27 Jun 23
Other Events
4:47pm
8-K
uba4i1ji7tvi
26 May 23
Entry into a Material Definitive Agreement
4:19pm
8-K
5dmqay tcu4c0hlyn5m
13 Apr 23
Bankruptcy or Receivership
4:38pm
8-K
hrx859 5as9tk7xi4apz
12 Apr 23
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
5:29pm
8-K
844fr
10 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
i8nf0cc
8 Mar 23
Departure of Directors or Certain Officers
4:42pm
8-K
wmn92nj
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
oo6syc6kh x1ixbef
20 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
dj8dm1g6u
10 Nov 22
PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update
5:12pm
8-K
4xfe24a56vdwsemm7b
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
ug4knz 5euc1
12 Aug 22
PLx Pharma Inc. Reports Second Quarter 2022 Results and Provides Business Update
7:00am
8-K
usiln6th3vyb yi
13 May 22
PLx Pharma Inc. Reports First Quarter 2022 Results and Provides Business Update
8:01am
8-K
w4ed0biwgg4mfjh
21 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
v7qok yvjl6jkbz
15 Mar 22
Regulation FD Disclosure
8:15am
8-K
kc5r els56
11 Mar 22
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
7:02am